NewsNew US patent approval for Episurf Medical

Episurf Medical (NASDAQ: EPIS B) has received another Notice of Allowance from the United States Patent and Trademark Office (USPTO). The patent, entitled “System of designing a guide tool and/or surgical kit tools and/or an implant comprising a positioning mark, covers specific features for accurate placement of Episurf Medical’s individualised joint implants.

“The Episealer® technology contains a number of delicate features, and the implant positioning solution for correct placement is one of these. We are happy to get that protected in the US. Episealer® is not just an implant but also comprises a userfriendly, proprietary set of surgical instruments and a damage marking report for surgical pre-planning”, comments Pål Ryfors, CEO, Episurf Medical.

For more  information, please contact:
Pål Ryfors, CEO, Episurf Medical
Tel:+46 (0) 709 62 36 69
Email: pal.ryfors@episurf.com